These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26531808)

  • 21. Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in Greece.
    Neonakis IK; Baritaki S; Georgiladakis A; Spandidos DA
    Roum Arch Microbiol Immunol; 2008; 67(1-2):10-3. PubMed ID: 19284160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.
    Menozzi MG; Eigner U; Covan S; Rossi S; Somenzi P; Dettori G; Chezzi C; Fahr AM
    J Clin Microbiol; 2006 Nov; 44(11):4085-94. PubMed ID: 17005752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 24. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Suto S; Zagar Z
    Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The product of the qacC gene of Staphylococcus epidermidis CH mediates resistance to beta-lactam antibiotics in gram-positive and gram-negative bacteria.
    Fuentes DE; Navarro CA; Tantaleán JC; Araya MA; Saavedra CP; Pérez JM; Calderón IL; Youderian PA; Mora GC; Vásquez CC
    Res Microbiol; 2005 May; 156(4):472-7. PubMed ID: 15862444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study.
    Juan C; Conejo MC; Tormo N; Gimeno C; Pascual Á; Oliver A
    J Antimicrob Chemother; 2013 Mar; 68(3):619-30. PubMed ID: 23143898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural Changes in Clinical and Microbiota Isolates of Klebsiella pneumoniae Carriers of Genes bla SHV, bla TEM, bla CTX-M, or bla KPC When Subject to β-Lactam Antibiotics.
    Veras DL; Lopes AC; da Silva GV; Gonçalves GG; de Freitas CF; de Lima FC; Maciel MA; Feitosa AP; Alves LC; Brayner FA
    ScientificWorldJournal; 2015; 2015():572128. PubMed ID: 26491715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the mixed inoculum on the species-identification and antimicrobial susceptibility test results by the automated microbial systems].
    Higa M; Kisanuki K; Yamane N; Nakasone I
    Rinsho Byori; 2008 Apr; 56(4):283-9. PubMed ID: 18516962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates.
    Giakkoupi P; Tzouvelekis LS; Daikos GL; Miriagou V; Petrikkos G; Legakis NJ; Vatopoulos AC
    J Clin Microbiol; 2005 Jan; 43(1):494-6. PubMed ID: 15635025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of different methods for determining beta-lactam susceptibility in Pseudomonas aeruginosa.
    Sapino B; Mazzuccato S; Solinas M; Gion M; Grandesso S
    New Microbiol; 2012 Oct; 35(4):491-4. PubMed ID: 23109018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rapid two-step algorithm detects and identifies clinical macrolide and beta-lactam antibiotic resistance in clinical bacterial isolates.
    Lu X; Nie S; Xia C; Huang L; He Y; Wu R; Zhang L
    J Microbiol Methods; 2014 Jul; 102():26-31. PubMed ID: 24769404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance.
    Suvorov M; Vakulenko SB; Mobashery S
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2937-42. PubMed ID: 17502412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Papagiannitsis CC; Loli A; Tzouvelekis LS; Tzelepi E; Arlet G; Miriagou V
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2185-8. PubMed ID: 17353248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
    Jang W; Park YJ; Park KG; Yu J
    J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggering of autolytic cell wall degradation in Escherichia coli by beta-lactam antibiotics.
    Kitano K; Tomasz A
    Antimicrob Agents Chemother; 1979 Dec; 16(6):838-48. PubMed ID: 93877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
    Hao Q; Wang H; Wang J; Dou J; Zhang M; Zhou W; Zhou C
    J Pept Sci; 2013 Mar; 19(3):173-80. PubMed ID: 23389882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
    Zhanel GG; Denisuik A; Vashisht S; Yachison C; Adam HJ; Hoban DJ
    J Antimicrob Chemother; 2014 Sep; 69(9):2448-52. PubMed ID: 24827891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion of beta-lactam antibiotics through oligomeric or monomeric porin channels of some gram-negative bacteria.
    Nitzan Y; Deutsch EB; Pechatnikov I
    Curr Microbiol; 2002 Dec; 45(6):446-55. PubMed ID: 12402087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.